Psychostimulants, antidepressants and neurokinin-1 receptor antagonists ('motor disinhibitors') have overlapping, but distinct, effects on monoamine transmission: The involvement of L-type Ca2+ channels and implications for the treatment of ADHD

Neuropharmacology

Volumn 87, Issue , 2014, Pages 9-18

  Stanford, S Clare ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antidepressant; Attention Deficit Hyperactivity Disorder (ADHD); L type calcium channel (LTCC); Monoamine transmission; Neurokinin receptor (NK1R) antagonist; Nifedipine; Psychostimulant

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; MONOAMINE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; PSYCHOSTIMULANT AGENT; SEROTONIN; VOLTAGE GATED CHLORIDE CHANNEL; BIOGENIC AMINE; CENTRAL STIMULANT AGENT;

AROUSAL; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; DEPRESSION; DISEASE COURSE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG RESPONSE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; LOCOMOTION; MENTAL STRESS; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PROTEIN DEFECT; PROTEIN PROTEIN INTERACTION; PSYCHOMOTOR RETARDATION; REVIEW; SEROTONINERGIC SYSTEM; ANIMAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOGENIC MONOAMINES; BRAIN; CALCIUM CHANNELS, L-TYPE; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; NEUROKININ-1 RECEPTOR ANTAGONISTS;

EID: 84907828011     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.03.021     Document Type: Review

References (144)

1. J.J. Anderson, S. Kuo, T.N. Chase, and T.M. Engber Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin1 receptors J. Pharmacol. Exp. Ther. 269 1994 1144 1151
2. T.A. Ansah, L.H. Wade, and D.C. Shockley Effects of calcium channel entry blockers on cocaine and amphetamine-induced motor activities and toxicities Life Sci. 53 1993 1947 1956
3. T.A. Ansah, L.H. Wade, P. Kopsombut, and D.C. Shockley Nifedipine potentiates the toxic effects of cocaine in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 26 2002 357 362
4. S.M. Antelman, A.J. Eichler, C.A. Black, and D. Kocan Interchangeability of stress and amphetamine in sensitization Science 207 1980 329 331
5. S.V. Argyropoulos, and D.J. Nutt Anhedonia revisited: is there a role for dopamine-targeting drugs for depression? J. Psychopharmacol. 27 2013 869 877
6. G. Aston-Jones, J. Rajkowski, and J. Cohen Role of locus coeruleus in attention and behavioral flexibility Biol. Psychiatry 46 1999 1309 1320
7. A. Auclair, C. Drouin, S. Cotecchia, J. Glowinski, and J.P. Tassin 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants Eur. J. Neurosci. 20 2004 3073 3084
8. D.T. Beattie, I.J. Beresford, H.E. Connor, F.H. Marshall, A.B. Hawcock, R.M. Hagan, J. Bowers, P.J. Birch, and P. Ward The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist Br. J. Pharmacol. 116 1995 3149 3157
9. C.R. Benedict, M. Fillenz, and C. Stanford Noradrenaline release in rats during prolonged cold-stress and repeated swim-stress Br. J. Pharmacol. 66 1979 521 524
10. L. Bert, D. Rodier, I. Bougault, N. Allouard, G. Le-Fur, P. Soubrie, and R. Steinberg Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801 Synapse 43 2002 62 69
11. C. Boselli, M.S. Barbone, and A. Lucchelli Older versus newer antidepressants: substance P or calcium antagonism? Can. J. Physiol. Pharmacol. 85 2007 1004 1011
12. T.Z. Bosy, and J.A. Ruth Differential inhibition of synaptosomal accumulation of [3H]-monoamines by cocaine, tropacocaine and amphetamine in four inbred strains of mice Pharmacol. Biochem. Behav. 34 1989 165 172
13. A. Bourson, A.J. Gower, A.K. Mir, and P.C. Moser The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity Br. J. Pharmacol. 98 1989 1312 1318
14. C. Burattini, G. Battistini, F. Tamagnini, and G. Aicardi Low frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid J. Neurophysiol. 111 2014 1046 1055
15. 2+ channels modulate depression-like behaviour in mice independent of deaf phenotype Int. J. Neuropsychopharmacol. 13 2010 499 513
16. R. Cadeddu, M. Ibba, A. Sadile, and E. Carboni Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? Psychopharmacology (Berl) 2013 Nov 13 [Epub ahead of print]
17. F. Casamassima, A.C. Hay, A. Benedetti, L. Lattanzi, G.B. Cassano, and R.H. Perlis L-type calcium channels and psychiatric disorders: a brief review Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B 2010 1373 1390
18. N.H. Chen, and M.E. Reith Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships J. Neurochem. 63 1994 1701 1713
19. C. Cohen, G. Perrault, and D.J. Sanger Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators Behav. Pharmacol. 8 1997 629 638
20. L.A. Colgan, S.L. Cavolo, K.G. Commons, and E.S. Levitan Action potential-independent and pharmacologically unique vesicular serotonin release from dendrites J. Neurosci. 32 2012 15737 15746
21. J.W. Constantine, W.S. Lebel, H.A. Woody, P.A. Benoit, E.A. Wolfgang, and D.R. Knight Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptors Eur. J. Pharmacol. 252 1994 275 282
22. F.C. Cruz, M.T. Marin, R.M. Leão, and C.S. Planeta Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system J. Neural Transm. 119 2012 415 424
23. J.F. Cryan, M.E. Page, and I. Lucki Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment Psychopharmacology (Berl) 182 2005 335 344
24. A. Czyrak, E. Mogilnicka, J. Siwanowicz, and J. Maj Some behavioral effects of repeated administration of calcium channel antagonists Pharmacol. Biochem. Behav. 35 1990 557 560
25. L.J. Dableh, K. Yashpal, J. Rochford, and J.L. Henry Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat Eur. J. Pharmacol. 2005 99 105 Jan 507
26. J.W. Dalley, D.E. Theobald, D.M. Eagle, F. Passetti, and T.W. Robbins Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex Neuropsychopharmacology 26 2002 716 728
27. P. Dayan, and A.J. Yu Phasic norepinephrine: a neural interrupt signal for unexpected events Network 17 2006 335 350
28. F. Deák, B. Lasztóczi, P. Pacher, G.L. Petheö, V. Kecskeméti, and A. Spät Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells Neuropharmacology 39 2000 1029 1036
29. D. Dobrev, and K.G. Andreas Modulation of potassium-evoked [3H]dopamine release from rat striatal slices by voltage-activated calcium channel ligands: effects of omega-conotoxin-MVIIC Neurochem. Res. 22 1997 1085 1093
30. J.A. Dudley, R.K. Weir, T.C. Yan, E.M. Grabowska, A.J. Grimmé, S. Amini, D.N. Stephens, S.P. Hunt, and S.C. Stanford Antagonism of L-type Ca(v) channels with nifedipine differentially affects performance of wildtype and NK1R-/- mice in the 5-Choice Serial Reaction-Time Task Neuropharmacology 64 2013 329 336
31. K. Ebner, and N. Singewald Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release Naunyn Schmiedeb. Arch. Pharmacol. 376 2007 73 82
32. K. Ebner, G.M. Singewald, N. Whittle, F. Ferraguti, and N. Singewald Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission Neuropsychopharmacology 33 2008 1929 1941
33. A. El Ayadi, I. Afailal, and M. Errami Effects of voltage-sensitive calcium channel blockers on extracellular dopamine levels in rat striatum Metab. Brain Dis. 16l 2001 121 131
34. T. Endoh Dual effects of neurokinin on calcium channel currents and signal pathways in neonatal rat nucleus tractus solitarius Brain Res. 1110 2006 116 127
35. -/- mice Eur. J. Neurosci. 25 2007 1195 1204
36. A.E. Fleckenstein, H.M. Haughey, R.R. Metzger, J.M. Kokoshka, E.L. Riddle, J.E. Hanson, J.W. Gibb, and G.R. Hanson Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function Eur. J. Pharmacol. 382 1999 45 49
37. N. Froger, A.M. Gardier, R. Moratalla, I. Alberti, I. Lena, C. Boni, C. De Felipe, N.M. Rupniak, S.P. Hunt, C. Jacquot, M. Hamon, and L. Lanfumey 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization J. Neurosci. 21 2001 8188 8197
38. L.J. Furmidge, A.W. Duggan, and G.W. Arbuthnott Substance P release from rat nucleus accumbens and striatum: an in vivo study using antibody microprobes Brain Res. 610 1993 234 241
39. C.J. Gardner, D.R. Armour, D.T. Beattie, J.D. Gale, A.B. Hawcock, G.J. Kilpatrick, D.J. Twissell, and P. Ward GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity Regul. Pept. 65 1996 45 53
40. S. Gee, I. Ellwood, T. Patel, F. Luongo, K. Deisseroth, and V.S. Sohal Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex J. Neurosci. 32 2012 4959 4971
41. T. Ginap, D.J. Dooley, and T.J. Feuerstein The non-dihydropyridine L-type voltage-sensitive calcium channel activator FPL 64176 enhances K(+)-evoked efflux of [3H]norepinephrine from rat neocortical slices Neurosci. Lett. 156 1993 35 38
42. T.P. Giordano, S.S. Satpute, J. Striessnig, B.E. Kosofsky, and A.M. Rajadhyaksha Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels J. Neurochem. 99 2006 1197 1206
43. 2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity J. Neurosci. 30 2010 17051 17062
44. S. Guard, S.J. Boyle, K.W. Tang, K.J. Watling, A.T. McKnight, and G.N. Woodruff The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences Br. J. Pharmacol. 110 1993 385 391
45. B.P. Guiard, N. Froger, M. Hamon, A.M. Gardier, and L. Lanfumey Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice J. Neurochem. 95 2005 1713 1723
46. P.G. Guyenet, and G.K. Aghajanian Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides Brain Res. 136 1977 178 184
47. S.P. Gygi, J.W. Gibb, M. Johnson, and G.R. Hanson Blockade of tachykinin NK1 receptors by CP-96345 enhances dopamine release and the striatal dopamine effects of methamphetamine in rats Eur. J. Pharmacol. 250 1993 177 180
48. N. Haddjeri, and P. Blier Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions Eur. J. Pharmacol. 600 2008 64 70
49. G.R. Hanson, L. Bush, K.A. Keefe, and M.E. Alburges Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine J. Neurochem. 82 2002 1171 1178
50. H. Hanyu, K. Hirao, S. Shimizu, T. Sato, A. Kiuchi, and T. Iwamoto Nilvadipine prevents cognitive decline of patients with mild cognitive impairment Int. J. Geriatr. Psychiatry 22 2007 1264 1266
51. T. Harrison, A.P. Owens, B.J. Williams, C.J. Swain, P.H. Baker, P.H. Hutson, S. Sadowski, and M.A. Cascieri Piperidine-ether based hNK1 antagonists 2: investigation of the effect of N-substitution Biorgan. Med. Chem. Lett. 5 1995 209 212
52. J.W. Hell, R.E. Westenbroek, C. Warner, M.K. Ahlijanian, W. Prystay, M.M. Gilbert, T.P. Snutch, and W.A. Catterall Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits J. Cell Biol. 123 1993 949 962
53. -/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects Neuropharmacology 48 2005 706 719
54. 2+ channels in rat brain regions and cultured neuronal cells Neurosci. Lett. 223 1997 169 172
55. A.L. Hudson, M.D. Lalies, and P. Silverstone Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex Can. J. Physiol. Pharmacol. 90 2012 803 809
56. P.H. Hutson, S. Patel, M.T. Jay, and C.L. Barton Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist Eur. J. Pharmacol. 484 2004 57 64
57. B.L. Jacobs, and E.C. Azmitia Structure and function of the brain serotonin system Physiol. Rev. 72 1992 165 229
58. S. Jordan, G.L. Kramer, P.K. Zukas, M. Moeller, and F. Petty In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine Synapse 18 1994 294 297
59. R. Karler, S.A. Turkanis, L.M. Partlow, and L.D. Calder Calcium channel blockers and behavioural sensitization Life Sci. 49 1991 165 170
60. S. Kasim, B.L. Blake, X. Fan, E. Chartoff, K. Egami, G.R. Breese, E.J. Hess, and H.A. Jinnah The role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in rodents Dev. Neurosci. 28 2006 505 517
61. Y. Kitaichi, T. Inoue, S. Nakagawa, S. Boku, A. Kakuta, T. Izumi, and T. Koyama Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats Eur. J. Pharmacol. 647 2010 90 96
62. T. Kobayashi, E. Hayashi, M. Shimamura, M. Kinoshita, and N.P. Murphy Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study Psychopharmacology (Berl) 197 2008 567 580 10.1007/s00213-008-1070-6 Epub 2008 Feb 15
63. K. Koda, Y. Ago, Y. Cong, Y. Kita, K. Takuma, and T. Matsuda Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice J. Neurochem. 114 2010 259 270
64. S.B. Kombian, K.V. Ananthalakshmi, S.S. Parvathy, and W.C. Matowe Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro Eur. J. Neurosci. 18 2003 303 311
65. M. Kraft, P. Noailles, and J.A. Angulo Substance P modulates cocaine-evoked dopamine overflow in the striatum of the rat brain Ann. N. Y. Acad. Sci. 937 2001 121 131
66. I. Krause, R. Cleper, Y. Kovalski, L. Sinai, and M. Davidovits Changes in behavior as an early symptom of renovascular hypertension in children Pediatr. Nephrol. 24 2009 2271 2274
67. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J. Neurochem. 68 1997 2032 2037 Erratum in: J Neurochem 1997 Sep;69(3):1332
68. R. Kuczenski, D.S. Segal, and M.L. Aizenstein Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics J. Neurosci. 11 1991 2703 2712
69. R. Kuczenski, D.S. Segal, A.K. Cho, and W. Melega Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine J. Neurosci. 15 1995 1308 1317
70. P.A. Lavoie, G. Beauchamp, and R. Elie Absence of stereoselectivity of some tricyclic antidepressants for the inhibition of depolarization-induced calcium uptake in rat cingulate cortex synaptosomes J. Psychiatry Neurosci. 19 1994 208 212
71. P.A. Lavoie, G. Beauchamp, and R. Elie Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes Can. J. Physiol. Pharmacol. 75 1997 983 987
72. F. Lejeune, A. Gobert, and M.J. Millan The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study Brain Res. 935 2002 134 139
73. S. Lelas, Y.W. Li, T.L. Wallace-Boone, M.T. Taber, A.E. Newton, R.L. Pieschl, C.D. Davis, T.F. Molski, K.S. Newberry, M.F. Parker, K.W. Gillman, J.J. Bronson, J.E. Macor, and N.J. Lodge NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the Gerbil forced swim test Neuropharmacology 73 2013 232 240
74. S.C. Licata, A.Y. Freeman, A.F. Pierce-Bancroft, and R.C. Pierce Repeated stimulation of L-type calcium channels in the rat ventral tegmental area mimics the initiation of behavioral sensitization to cocaine Psychopharmacology (Berl) 152 2000 110 118
75. S.M. Lillrank, B.K. Lipska, B.S. Kolachana, and D.R. Weinberger Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage J. Neural Transm. 106 1999 183 196
76. 2+ channels Eur. J. Pharmacol. 252 1994 275 282
77. T.M. Loonam, P.A. Noailles, J. Yu, J.P. Zhu, and J.A. Angulo Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum Life Sci. 73 2003 727 739
78. Q.P. Ma, and C. Bleasdale Modulation of brain stem monoamines and gamma-aminobutyric acid by NK1 receptors in rats Neuroreport 13 2002 1809 1812
79. H. Maruya, Y. Watanabe, M. Okita, G.F. Lawlor, H. Utsumi, and T. Niitsuma Inhibitory effects of D2 agonists by striatal injection on excessive release of dopamine and hyperactivity induced by Bay K 8644 in rats Neuroscience 118 2003 1091 1098
80. K.A. Maubach, K. Martin, G. Chicchi, T. Harrison, A. Wheeldon, C.J. Swain, M.J. Cumberbatch, N.M. Rupniak, and G.R. Seabrook Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus Neuroscience 109 2002 609 617
81. S. McLean, A. Ganong, P.A. Seymour, R.M. Snider, M.C. Desai, T. Rosen, D.K. Bryce, K.P. Longo, L.S. Reynolds, and G. Robinson Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor J. Pharmacol. Exp. Ther. 267 1993 472 479
82. A. Meneses, and E. Hong Spontaneously hypertensive rats: a potential model to identify drugs for treatment of learning disorders Hypertension 31 1998 968 972
83. D.N. Middlemiss The calcium channel activator, Bay K 8644, enhances K+-evoked efflux of acetylcholine and noradrenaline from rat brain slices Naunyn Schmiedeb. Arch. Pharmacol. 331 1985 114 116
84. D.N. Middlemiss, and M.A. Spedding A functional correlate for the dihydropyridine binding site in rat brain Nature 314 1985 94 96
85. M.J. Millan, F. Lejeune, G. De Nanteuil, and A. Gobert Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats J. Neurochem. 276 2001 1949 1954
86. N.A. Moore, G. Rees, G. Sanger, and S. Awere Effect of L-type calcium channel modulators on stimulant-induced hyperactivity Neuropharmacology 32 1993 719 720
87. O. Nordström, S. Braesch-Andersen, and T. Bartfai Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736) Acta Physiol. Scand. 126 1986 115 119
88. Y. Ohya, T. Tsuchihashi, S. Kagiyama, I. Abe, and M. Fujishima Single L-type calcium channels in smooth muscle cells from resistance arteries of spontaneously hypertensive rats Hypertension 31 1998 1125 1129
89. M.E. Page, and I. Lucki Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex Neuropsychopharmacology 27 2002 237 247
90. 2+ channel blockers in rhesus monkey Eur. J. Pharmacol. 412 2001 139 144
91. W.H. Pan, Y.J. Lai, and N.H. Chen Differential effects of chloral hydrate and pentobarbital sodium on a cocaine level and its catecholamine response in the medial prefrontal cortex: a comparison with conscious rats J. Neurochem. 64 1995 2653 2659
92. L. Pani, A. Kuzmin, M. Diana, G. De Montis, G.L. Gessa, and Z.L. Rossetti Calcium receptor antagonists modify cocaine effects in the central nervous system differently Eur. J. Pharmacol. 190 1990 217 221
93. R.C. Pierce, E.A. Quick, D.C. Reeder, Z.R. Morgan, and P.W. Kalivas Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine J. Pharmacol. Exp. Ther. 286 1998 1171 1176
94. 2+-antagonist nimodipine on dopamine metabolism in mouse brain J. Neural Transm. 66 1986 171 187
95. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair in rats: a new model sensitive to antidepressant treatments Eur. J. Pharmacol. 47 1978 379 391
96. 2+ channels in mesenteric and skeletal arteries of SHR Hypertension 40 2002 214 219
97. O. Pucilowski, P.L. Garges, A.H. Rezvani, S. Hutheson, and D.S. Janowsky Verapamil suppresses d-amphetamine-induced place preference conditioning Eur. J. Pharmacol. 240 1993 89 92
98. O. Pucilowski, A. Płaźnik, and D.H. Overstreet Isradipine suppresses amphetamine-induced conditioned place preference and locomotor stimulation in the rat Neuropsychopharmacology 12 1995 239 244
99. I.A. Pullar, and J.D. Findlay Effect of voltage-sensitive calcium channel antagonists on the release of 5-hydroxytryptamine from rat hippocampus in vivo J. Neurochem. 59 1992 553 559
100. M. Pum, R.J. Carey, J.P. Huston, and C.P. Müller Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats Psychopharmacology (Berl) 193 2007 375 390
101. N. Rasmussen Making the first anti-depressant: amphetamine in American medicine, 1929-1950 J. Hist. Med. Allied Sci. 61 2006 288 323
102. M.S. Reid, M. Herrera-Marschitz, and U. Ungerstedt Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats J. Neurochem. 57 1991 970 974
103. G. Renoldi, and R.W. Invernizzi Blockade of tachykinin NK1 receptors attenuates stress-induced rise of extracellular noradrenaline and dopamine in the rat and gerbil medial prefrontal cortex J. Neurosci. Res. 84 2006 961 968
104. R. Rogério, and R.N. Takahashi Some calcium channel antagonists have no effect on the open-field behavior of rats nor do they interact with cocaine Braz. J. Med. Biol. Res. 23 1990 1153 1155
105. S. Rosenzweig-Lipson, and J.E. Barrett Modification of the behavioral effects of (+/-)BAY k 8644, cocaine and d-amphetamine by L-type calcium channel blockers in squirrel monkeys J. Pharmacol. Exp. Ther. 274 1995 842 851
106. D. Ross, and N. Monis Regional and subcellular distribution of [3H]nitrendipine binding sites in SHR and WKY rats J. Cardiovasc. Pharmacol. 12 Suppl. 4 1988 S94 S97
107. H.L. Rowley, R.S. Kulkarni, J. Gosden, R.J. Brammer, D. Hackett, and D.J. Heal Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats J. Psychopharmacol. 28 2014 254 269
108. N.M. Rupniak, and A. Jackson Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs Eur. J. Pharmacol. 262 1994 171 175
109. N.M. Rupniak, S. Boyce, A.R. Williams, G. Cook, J. Longmore, G.R. Seabrook, M. Caeser, S.D. Iversen, and R.G. Hill Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580 Br. J. Pharmacol. 110 1993 1607 1613
110. -/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs Behav. Pharmacol. 12 2001 497 508
111. J. Sabrià, C. Pastor, M.V. Clos, A. Garcia, and A. Badia Involvement of different types of voltage-sensitive calcium channels in the presynaptic regulation of noradrenaline release in rat brain cortex and hippocampus J. Neurochem. 64 1995 2567 2571
112. F.S. Sagala, D. Harnack, E. Bobrov, R. Sohr, C. Gertler, D. James Surmeier, and A. Kupsch Neurochemical characterization of the striatum and the nucleus accumbens in L-type Ca(v)1.3 channels knockout mice Neurochem. Int. 60 2012 229 232
113. J.D. Salamone, and M. Correa The mysterious motivational functions of mesolimbic dopamine Neuron 76 2012 470 485
114. L.C. Schenberg, L.P. Marçal, F. Seeberger, M.R. Barros, and E.C. Sudré L-type calcium channels selectively control the defensive behaviors induced by electrical stimulation of dorsal periaqueductal gray and overlying collicular layers Behav. Brain Res. 111 2000 175 185
115. 2+ channels Eur. J. Pharmacol. 219 1992 491 492
116. B.L. Schwartz, M. Fay-McCarthy, K. Kendrick, R.B. Rosse, and S.I. Deutsch Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia Clin. Neuropharmacol. 20 1997 364 370
117. H.W. Shen, Y. Hagino, H. Kobayashi, K. Shinohara-Tanaka, K. Ikeda, H. Yamamoto, T. Yamamoto, K.P. Lesch, D.L. Murphy, F.S. Hall, G.R. Uhl, and I. Sora Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters Neuropsychopharmacology 29 2004 1790 1799
118. 2+ channels J. Clin. Investig. 113 2004 1430 1439
119. M.J. Sinnegger-Brauns, I.G. Huber, A. Koschak, C. Wild, G.J. Obermair, U. Einzinger, J.C. Hoda, S.B. Sartori, and J. Striessnig Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms Mol. Pharmacol. 75 2009 407 414
120. S.C. Stanford Central noradrenergic neurones and stress Pharmacol. Ther. 68 1995 297 342
121. S.C. Stanford Prozac: panacea or puzzle? Trends Pharmacol. Sci. 17 1996 150 154
122. S.C. Stanford Stress: a major variable in the psychopharmacologic response Pharmacol. Biochem. Behav. 54 1996 211 217
123. B.J. Stanford, and S.C. Stanford Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine? J. Psychopharmacol. 13 1999 313 317
124. S.C. Stanford, B.J. Stanford, and P.K. Gillman Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium J. Psychopharmacol. 24 2010 1433 1438
125. L. Steru, R. Chermat, B. Thierry, J.A. Mico, A. Lenegre, M. Steru, P. Simon, and R.D. Porsolt The automated tail suspension test: a computerized device which differentiates psychotropic drugs Prog. Neuropsychopharmacol. Biol. Psychiatry 11 1987 659 671
126. 2+ channel isoforms for brain function Biochem. Soc. Trans. 34 2006 903 909
127. N. Sukiasyan, H. Hultborn, and M. Zhang Distribution of calcium channel Ca(V)1.3 immunoreactivity in the rat spinal cord and brain stem Neuroscience 159 2008 217 235
128. M. Tatsumi, K. Groshan, R.D. Blakely, and E. Richelson Pharmacological profile of antidepressants and related compounds at human monoamine transporters Eur. J. Pharmacol. 340 1997 249 258
129. A. Tazi, M. Farh, and F. Hakkou Behavioral effects of a calcium channel antagonist: nifedipine Fundam. Clin. Pharmacol. 5 1991 229 236
130. C. Trueta, and F.F. De-Miguel Extrasynaptic exocytosis and its mechanisms: a source of molecules mediating volume transmission in the nervous system Front. Physiol. 3 2012 Sep 4 319 10.3389/fphys.2012.00319 eCollection 2012
131. 2+ currents Prog. Neurobiol. 96 2012 1 31
132. A.I. Vislobokov, V.V. Mantsev, and A.V. Kuzmin Cocaine, amphetamine and cathinone, but not nomifensine and pargyline increase calcium inward current in internally perfused neurons Life Sci. 52 1993 PL261 PL265
133. M.P. Viveros, S. Martín, M.J. Ormazabal, M.J. Alfaro, and M.I. Martín Effects of nimodipine and nifedipine upon behavior and regional brain monoamines in the rat Psychopharmacology 127 1996 123 132
134. 2+ channel in the brain Life Sci. 62 1998 1671 1675
135. -/- and wild type mice in the 5-Choice Serial Reaction-Time Task J. Psychopharmacol. 28 2013 270 281 2014
136. J.J. Woodward, and S.W. Leslie Bay K 8644 stimulation of calcium entry and endogenous dopamine release in rat striatal synaptosomes antagonized by nimodipine Brain Res. 370 1986 397 400
137. T.C. Yan, S.P. Hunt, and S.C. Stanford Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder Neuropharmacology 57 2009 627 635
138. T.C. Yan, A. McQuillin, A. Thapar, P. Asherson, S.P. Hunt, S.C. Stanford, and H. Gurling NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD J. Psychopharmacol. 24 2010 27 38
139. T.C. Yan, J.A. Dudley, R.K. Weir, E.M. Grabowska, Y. Peña-Oliver, T.L. Ripley, S.P. Hunt, D.N. Stephens, and S.C. Stanford Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day PLoS One 6 2011 e17586 10.1371/journal.pone.0017586
140. T. Yoshikawa, N. Yoshida, and M. Oka The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist Br. J. Pharmacol. 133 2001 253 260
141. Q. Zhang, J.X. Li, J.W. Zheng, R.K. Liu, and J.H. Liang L-type Ca(2+) channel blockers inhibit the development but not the expression of sensitization to morphine in mice Eur. J. Pharmacol. 467 2003 145 150
142. L. Zhang, M. Ouyang, C.R. Ganellin, and S.A. Thomas The slow after hyperpolarization: a target of β1-adrenergic signaling in hippocampus-dependent memory retrieval J. Neurosci. 33 2013 5006 5016
143. 2+ releasing system in rat striatum Neurosci. Lett. 362 2004 244 248
144. A. Zocchi, G. Varnier, R. Arban, C. Griffante, L. Zanetti, L. Bettelini, M. Marchi, P.A. Gerrard, and M. Corsi Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse Neurosci. Lett. 345 2003 73 76